UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human li...

UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human livers. This project leverages AI-driven design to solve the vascularization bottleneck, enabling high-resolution blood vessel fabrication in mere seconds. By integrating clinical-grade stem cell technology, the initiative aims to eliminate donor waitlists for 12,000 plus patients annually. This transition to industrial-scale bio-manufacturing marks a systemic shift in regenerative medicine. 🧬🏥⚙️ #3DBioprinting #ARPAH #RegenerativeMedicine #AdditiveManufacturing #UCSanDiego